clive roper.jpeg

CLIVE ROPER,
BSc PhD CBiol CSci ERT FRSB

Director, Roper Toxicology Consulting Limited

 

EXPERIENCE

March 2021 - Present

Director, Owner and Founder, Roper Toxicology Consulting Limited

April 2021 - Present

January 2021 - Present

UK NC3Rs

August 2010 - February 2020

Charles River Laboratories, Edinburgh, UK

  • People management

  • Multimillion dollar budget

  • Business and department growth

  • BD

  • NAMs development

  • In vitro skin absorption

  • In vitro respiratory toxicology

  • In vitro safety pharmacology

  • Genetic toxicology

  • In vitro metabolism

  • Speaker

  • Leader

  • 3Rs working group (corporate)

  • Technology evaluation (corporate)

March 2020 - February 2021

Charles River Laboratories, Edinburgh, UK

  • People management

  • Multimillion dollar budget

  • Business and department growth

  • BD

  • NAMs development

  • In vitro skin absorption

  • In vitro respiratory toxicology

  • In vitro safety pharmacology

  • Advanced in vitro tissue models

  • Speaker

  • Leader

  • 3Rs working group (corporate)

  • Technology evaluation (corporate)

June 1996 - August 2010

Charles River Laboratories Edinburgh Limited

  • Scientific Manager (January 2003 - August 2010)

  • Study Director (July 1997 - December 2002)

  • Research Officer (June 1996 - June 1997).

 

EDUCATION

October 1990 - April 1994

DOCTOR OF PHILOSOPHY

Department of Environmental and Occupational Medicine, Newcastle University & Unilever Research, Sharnbrook, Bedfordshire, UK.

  • In vitro skin absorption and toxicology

  • PhD thesis: In vitro approaches to the prediction of percutaneous absorption and metabolism: a study of ethoxylates.

September 1987 - June 1990

Department of Agricultural Biochemistry and Nutrition, Newcastle University.

  • Agricultural Biochemistry and Nutrition, BSc (Hons) 2:1.

BACHELOR OF SCIENCE HONOURS DEGREE

 

ACHIEVEMENTS

Developing a NAM for respiratory toxicology, representing this to the US EPA Special Advisory Panel, receiving a personal invitation to attend the EPA NAM conferences, being acknowledged as an EPA stakeholder for their animal free 2035 plans and writing the NAM as a Case Study now accepted for publication by the OECD
• I am an active Member of the Board of both the North American 3Rs Collaborative (NA3RsC) and
UK NC3Rs developing North American and UK 3Rs strategy
• 4 of my peer review papers are quoted in OECD test guidelines (OECD 428 and OECD 492)

ocular v3.png